241 related articles for article (PubMed ID: 35187964)
1. Analysis of the Correlation Between the Ratio of Monocytes to High-Density Lipoprotein Cholesterol and in-Stent Restenosis in Patients with Premature Coronary Heart Disease.
Chen BW; Liu JJ; Xing JH; Liu HD; Wei YZ; Xue XF; Gu HP; Tao HL
Clin Appl Thromb Hemost; 2022; 28():10760296221079334. PubMed ID: 35187964
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for revascularization and in-stent restenosis in patients with triple-vessel disease after second-generation drug-eluting stent implantation: a retrospective analysis.
Zeng M; Yan X; Wu W
BMC Cardiovasc Disord; 2021 Sep; 21(1):446. PubMed ID: 34535088
[TBL] [Abstract][Full Text] [Related]
3. A potential marker of bare metal stent restenosis: monocyte count - to- HDL cholesterol ratio.
Ucar FM
BMC Cardiovasc Disord; 2016 Oct; 16(1):186. PubMed ID: 27716070
[TBL] [Abstract][Full Text] [Related]
4. The Predictive Value of Monocyte Count to High-Density Lipoprotein Cholesterol Ratio in Restenosis After Drug-Eluting Stent Implantation.
Nan J; Meng S; Hu H; Jia R; Chen C; Peng J; Jin Z
Int J Gen Med; 2020; 13():1255-1263. PubMed ID: 33269001
[TBL] [Abstract][Full Text] [Related]
5. Remnant lipoproteins play an important role of in-stent restenosis in type 2 diabetes undergoing percutaneous coronary intervention: a single-centre observational cohort study.
Qin Z; Zhou K; Li YP; Wang JL; Cheng WJ; Hu CP; Shi C; He H; Zhou YJ
Cardiovasc Diabetol; 2019 Jan; 18(1):11. PubMed ID: 30691501
[TBL] [Abstract][Full Text] [Related]
6. Association of the monocytes to high-density lipoprotein cholesterol ratio with in-stent neoatherosclerosis and plaque vulnerability: An optical coherence tomography study.
Rong J; Gu N; Tian H; Shen Y; Deng C; Chen P; Ma S; Ma Y; Hu X; Zhao R; Shi B
Int J Cardiol; 2024 Feb; 396():131417. PubMed ID: 37802300
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of the monocyte-to-high-density lipoprotein cholesterol ratio to predict bare metal stent restenosis.
Yilmaz S; Akboga MK; Sen F; Balcı KG; Aras D; Temizhan A; Aydogdu S
Biomark Med; 2016 Sep; 10(9):959-66. PubMed ID: 27537215
[TBL] [Abstract][Full Text] [Related]
8. Coronary CT angiography-derived quantitative markers for predicting in-stent restenosis.
Tesche C; De Cecco CN; Vliegenthart R; Duguay TM; Stubenrauch AC; Rosenberg RD; Varga-Szemes A; Bayer RR; Yang J; Ebersberger U; Baquet M; Jochheim D; Hoffmann E; Steinberg DH; Chiaramida SA; Schoepf UJ
J Cardiovasc Comput Tomogr; 2016; 10(5):377-83. PubMed ID: 27431607
[TBL] [Abstract][Full Text] [Related]
9. A prediction model based on platelet parameters, lipid levels, and angiographic characteristics to predict in-stent restenosis in coronary artery disease patients implanted with drug-eluting stents.
Gai MT; Zhu B; Chen XC; Liu F; Xie X; Gao XM; Ma X; Fu ZY; Ma YT; Chen BD
Lipids Health Dis; 2021 Sep; 20(1):118. PubMed ID: 34587955
[TBL] [Abstract][Full Text] [Related]
10. The relationship between fibrinogen-to-albumin ratio and in-stent restenosis in patients with coronary artery disease undergoing drug-eluting stenting.
Chen T; Sun JL; Zhang J
Coron Artery Dis; 2020 Nov; 31(7):586-589. PubMed ID: 32271235
[TBL] [Abstract][Full Text] [Related]
11. Remnant Lipoprotein Cholesterol Independently Associates With In-Stent Restenosis After Drug-Eluting Stenting for Coronary Artery Disease.
Xu X; Pandit RU; Han L; Li Y; Guo X
Angiology; 2019 Oct; 70(9):853-859. PubMed ID: 31167539
[TBL] [Abstract][Full Text] [Related]
12. Levels of plasma Quaking and cyclooxygenase-2 predict in-stent restenosis in patients with coronary artery disease after percutaneous coronary intervention.
Wang P; Kuang Y; Liu Y; Zhang Y; Gao H; Ma Q
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jun; 47(6):739-747. PubMed ID: 35837773
[TBL] [Abstract][Full Text] [Related]
13. CHA
Zhao SG; Xu JJ; Tao ZH; Jin L; Liu Q; Zheng WY; Jiang LQ; Wang NF
J Int Med Res; 2019 Jun; 47(6):2533-2544. PubMed ID: 31039653
[TBL] [Abstract][Full Text] [Related]
14. Clinical analysis of lectin-like oxidized low-density lipoprotein receptor-1 in patients with in-stent restenosis after percutaneous coronary intervention.
Liu J; Liu Y; Jia K; Huo Z; Huo Q; Liu Z; Li Y; Han X; Wang R
Medicine (Baltimore); 2018 Apr; 97(17):e0366. PubMed ID: 29702981
[TBL] [Abstract][Full Text] [Related]
15. Non-Fasting Hypertriglyceridemia as an Independent Risk Factor for Coronary In-Stent Restenosis after Primary Bare Metal Stent Implantation in Patients with Coronary Artery Disease.
Yoshimura M; Umemoto S; Kawano R; Hiromoto M; Yamada M; Fujimura T; Tanaka M; Nao T; Miura T; Yano M
Int Heart J; 2021; 62(5):970-979. PubMed ID: 34588411
[TBL] [Abstract][Full Text] [Related]
16. Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials.
Doi H; Maehara A; Mintz GS; Yu A; Wang H; Mandinov L; Popma JJ; Ellis SG; Grube E; Dawkins KD; Weissman NJ; Turco MA; Ormiston JA; Stone GW
JACC Cardiovasc Interv; 2009 Dec; 2(12):1269-75. PubMed ID: 20129555
[TBL] [Abstract][Full Text] [Related]
17. Influence of insulin resistance on in-stent restenosis in patients undergoing coronary drug-eluting stent implantation after long-term angiographic follow-up.
Zhao LP; Xu WT; Wang L; Li H; Shao CL; Gu HB; Chan SP; Xu HF; Yang XJ
Coron Artery Dis; 2015 Jan; 26(1):5-10. PubMed ID: 25211654
[TBL] [Abstract][Full Text] [Related]
18. Relationship between uric acid to albumin ratio and in-stent restenosis in patients with coronary artery disease undergoing drug-eluting stenting.
Liu W; Ding K; Bao J; Hu Y; Gui Y; Ye L; Wang L
Coron Artery Dis; 2023 Dec; 34(8):589-594. PubMed ID: 37855441
[TBL] [Abstract][Full Text] [Related]
19. FGF-23 correlates with endocrine and metabolism dysregulation, worse cardiac and renal function, inflammation level, stenosis degree, and independently predicts in-stent restenosis risk in coronary heart disease patients underwent drug-eluting-stent PCI.
Song T; Fu Y; Wang Y; Li W; Zhao J; Wang X; Wang H; Zhao Y; Fu X
BMC Cardiovasc Disord; 2021 Jan; 21(1):24. PubMed ID: 33413149
[TBL] [Abstract][Full Text] [Related]
20. Random forest vs. logistic regression: Predicting angiographic in-stent restenosis after second-generation drug-eluting stent implantation.
Jiang Z; Tian L; Liu W; Song B; Xue C; Li T; Chen J; Wei F
PLoS One; 2022; 17(5):e0268757. PubMed ID: 35604911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
